Specific Oncolytic Adenovirus Driven by Human A33 Promoter Region for Colorectal Cancer Therapy

被引：0
|
作者：
Cafferata, Eduardo G. [1 ,2 ]
Maccio, Daniela R. [1 ]
Lopez, Maria V. [1 ]
Viale, Diego L. [1 ]
Podhajcer, Osvaldo L. [1 ]
机构：
[1] UBA, CONICET, Leloir Inst, Gene Therapy Lab, Buenos Aires, DF, Argentina
[2] CeNaGeM ANLIS Carlos G Malbran, Expt Genet Dept, Buenos Aires, DF, Argentina
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.713
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
637
引用
收藏
页码：S245 / S245
页数：1
相关论文
共 50 条
  • [1] Gene therapy specific for ovarian cancer by IAI.3B promoter-driven oncolytic adenovirus
    Hamada, Katsuyuki
    CANCER RESEARCH, 2006, 66 (08)
  • [2] A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis
    Murer, Patrizia
    Pluess, Louis
    Neri, Dario
    MABS, 2020, 12 (01)
  • [3] Heterogeneous expression of A33 in colorectal cancer: Possible explanation for A33 antibody treatment failure
    Baptistella, A. R.
    Salles Dias, M. V.
    Aguiar Junior, S.
    Begnami, M. D.
    Martins, V. R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S45 - S45
  • [4] Heterogeneous expression of A33 in colorectal cancer: possible explanation for A33 antibody treatment failure
    Baptistella, Antuani R.
    Salles Dias, Marcos Vinicios
    Aguiar, Samuel, Jr.
    Begnami, Maria D.
    Martins, Vilma R.
    ANTI-CANCER DRUGS, 2016, 27 (08) : 734 - 737
  • [5] Ovarian Cancer-Specific Gene Therapy by Oncolytic Adenovirus
    Hamada, Katsuyuki
    MOLECULAR THERAPY, 2006, 13 : S56 - S56
  • [6] Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
    Fujiwara, Toshiyoshi
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    CURRENT CANCER THERAPY REVIEWS, 2015, 11 (03) : 178 - 187
  • [7] A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
    Leja, Justyna
    Dzojic, Helena
    Gustafson, Elisabet
    Oberg, Kjell
    Giandomenico, Valeria
    Essand, Magnus
    CLINICAL CANCER RESEARCH, 2007, 13 (08) : 2455 - 2462
  • [8] A Novel A33 Promoter-Based Conditionally Replicative Adenovirus Suppresses Tumor Growth and Eradicates Hepatic Metastases in Human Colon Cancer Models
    Cafferata, Eduardo G.
    Maccio, Daniela R.
    Lopez, Maria V.
    Viale, Diego L.
    Carbone, Cecilia
    Mazzolini, Guillermo
    Podhajcer, Osvaldo L.
    CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3037 - 3049
  • [9] Novel human monoclonal antibodies specific to the A33 glycoprotein recognizes prostate cancer
    Ben Jemaa, Awatef
    Ben Slimen, Chaima
    Oueslati, Ridha
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1586 - 1586
  • [10] Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo
    Yang, Guohua
    Meng, Xiangwei
    Sun, Lili
    Hu, Ningning
    Jiang, Shuang
    Sheng, Yuan
    Chen, Zhifei
    Zhou, Ye
    Chen, Dexing
    Li, Xiao
    Jin, Ningyi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (02) : 327 - 334
12345